Evidence map›Paper›PMID 22723583›Full record

Trial reportDiabetes care2012

Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial.

Ann V Schwartz, Karen L Margolis, Deborah E Sellmeyer, Eric Vittinghoff, Walter T Ambrosius, Denise E Bonds, Robert G Josse, Adrian M Schnall, Debra L Simmons, Trisha F Hue and 7 more

Registry-linked trialOpen access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Diabetes care, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00324350 (Intensive Glycemic Control and Skeletal Health Study - Ancillary Study to the Action to Control Cardiovascular Risk in Diabetes Trial), which is not on this map. Cited by 58 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 3 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00324350 phase3completednot on this map

Intensive Glycemic Control and Skeletal Health Study - Ancillary Study to the Action to Control Cardiovascular Risk in Diabetes Trial (ACCORD-BONE)

TypeinterventionalSponsorUniversity of California, San FranciscoRan2003 to 2009Enrolled7,287ConditionsAtherosclerosis, Cardiovascular Diseases, Hypercholesterolemia, HypertensionArmshypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 3 syntheses or guidelines pooled it, 131 citations in OpenAlex.

  1. Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Pooled it
  2. Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.The Journal of clinical endocrinology and metabolism · 2019
    Guideline
  3. Type 1 diabetes and risk of fracture: meta-analysis and review of the literature.Diabetic medicine : a journal of the British Diabetic Association · 2015
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Obesity and Skeletal Fragility.The Journal of clinical endocrinology and metabolism · 2024
    Review
  14. Article
  15. Article
  16. Musculoskeletal complications in patients with diabetes mellitus.The Korean journal of internal medicine · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 2 countries.

Ann V SchwartzDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA. aschwartz@psg.ucsf.edu
Karen L Margolis
Deborah E Sellmeyer
Eric Vittinghoff
Walter T Ambrosius
Denise E Bonds
Robert G Josse
Adrian M Schnall
Debra L Simmons
Trisha F Hue
Lisa Palermo
Bruce P Hamilton
Jennifer B Green
Hal H Atkinson
Patrick J O'Connor
Rex W Force
Douglas C Bauer
University of California, San Francisco · USRegions Hospital · USWake Forest University · USBaltimore VA Medical Center · USCase Western Reserve University · USCentral Arkansas Veterans Healthcare System · USDuke Medical Center · USIdaho State University · USJohns Hopkins University · USNational Heart Lung and Blood Institute · USUniversity of Toronto · CA

Funding

Intensive Glycemic Control and Skeletal HealthR01DK069514 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHWARTZ, ANN V · 2005 to 2009
$2.4M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095183 · HC · MINNEAPOLIS MEDICAL RESEARCH FDN, INC. · PI GRIMM, RICHARD H · 1999 to 2000
$1.9M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095181 · HC · CASE WESTERN RESERVE UNIVERSITY · PI THIBONNIER, MARC · 1999 to 2000
$1.8M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095184 · HC · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BIGGER, J T · 1999 to 2000
$1.7M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095182 · HC · WAKE FOREST UNIVERSITY · PI GOFF, DAVID C · 1999 to 2000
$1.6M
Biomarker Research in Musculoskeleton DiseaseK24AR051895 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BAUER, DOUGLAS C · 2005 to 2015
$1.5M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUS-N01HC95178N01HC095178 · HC · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BYINGTON, ROBERT · 1999 to 2006
$1.5M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETER MELLLITN01HC095180 · HC · UNIVERSITY OF WASHINGTON · PI PROBSTFIELD, JEFFREY · 1999 to 2000
$1.5M
S-nitrosothiol analyzer for the clinical diagnosis of cardiovascular disease markR44HL095181 · NHLBI · ACCORD BIOMATERIALS, INC. · PI PISANO, MICHAEL R · 2010 to 2011
$1.4M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095179 · HC · MCMASTER UNIVERSITY · PI GERSTEIN, HERTZEL C · 1999 to 2000
$1.3M
S-nitrosothiol analyzer for the clinical diagnosis of cardiovascular disease markR43HL095181 · NHLBI · ACCORD BIOMATERIALS, INC. · PI HANDA, HILTESH · 2009 to 2009
$93k
NHLBI NIH HHS IAA-Y1-HC-1010NHLBI NIH HHS IAA-Y1-HC-9035NHLBI NIH HHS N01 HC095178NHLBI NIH HHS N01 HC095179NHLBI NIH HHS N01 HC095180NHLBI NIH HHS N01 HC095181NHLBI NIH HHS N01 HC095182NHLBI NIH HHS N01 HC095183NHLBI NIH HHS N01 HC095184NHLBI NIH HHS N01-HC-95178NHLBI NIH HHS N01-HC-95179NHLBI NIH HHS N01-HC-95180NHLBI NIH HHS N01-HC-95181NHLBI NIH HHS N01-HC-95182NHLBI NIH HHS N01-HC-95183NHLBI NIH HHS N01-HC-95184NHLBI NIH HHS Y01 HC001010NHLBI NIH HHS Y01 HC009035NIAMS NIH HHS K24 AR051895NIDDK NIH HHS R01 DK069514NIDDK NIH HHS R01DK069514
6 · The paper itself

Abstract

objectiveOlder adults with type 2 diabetes are at high risk of fractures and falls, but the effect of glycemic control on these outcomes is unknown. To determine the effect of intensive versus standard glycemic control, we assessed fractures and falls as outcomes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) randomized trial. RESEARCH DESIGN AND

methodsACCORD participants were randomized to intensive or standard glycemia strategies, with an achieved median A1C of 6.4 and 7.5%, respectively. In the ACCORD BONE ancillary study, fractures were assessed at 54 of the 77 ACCORD clinical sites that included 7,287 of the 10,251 ACCORD participants. At annual visits, 6,782 participants were asked about falls in the previous year.

resultsDuring an average follow-up of 3.8 (SD 1.3) years, 198 of 3,655 participants in the intensive glycemia and 189 of 3,632 participants in the standard glycemia group experienced at least one nonspine fracture. The average rate of first nonspine fracture was 13.9 and 13.3 per 1,000 person-years in the intensive and standard groups, respectively (hazard ratio 1.04 [95% CI 0.86-1.27]). During an average follow-up of 2.0 years, 1,122 of 3,364 intensive- and 1,133 of 3,418 standard-therapy participants reported at least one fall. The average rate of falls was 60.8 and 55.3 per 100 person-years in the intensive and standard glycemia groups, respectively (1.10 [0.84-1.43]).

conclusionsCompared with standard glycemia, intensive glycemia did not increase or decrease fracture or fall risk in ACCORD.

Indexed as

Accidental FallsAdultAgedBlood GlucoseBone DensityCardiovascular DiseasesDiabetes Mellitus, Type 2FemaleFractures, BoneGlycated HemoglobinHumansHypoglycemic AgentsMaleMiddle AgedRisk FactorsBlood GlucoseGlycated HemoglobinHypoglycemic Agents

Identifiers

PMID22723583
PMCPMC3379596
OpenAlexW2106369027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.